Related Experiment Videos
The treatment of perennial rhinitis with intranasal beclomethasone dipropionate
The Practitioner
|February 1, 1977
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Vagal nerve stimulation dynamically alters anxiety-like behavior in rats.
Brain stimulation·2025
Little appetite for obesity: meta-analysis of the effects of maternal obesogenic diets on offspring food intake and body mass in rodents.
International journal of obesity (2005)·2015
Transgenerational effects of caloric restriction on appetite: a meta-analysis.
Obesity reviews : an official journal of the International Association for the Study of Obesity·2014
Analysis of HMW glutenin subunits encoded by chromosome 1A of bread wheat (Triticum aestivum L.) indicates quantitative effects on grain quality.
TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Improving pain control in diabetic neuropathy.
The Practitioner·2017
Tailor management to the patient with fibroids.
The Practitioner·2017
Preventing stroke and assessing risk in women.
The Practitioner·2017
Early referral improves long-term outcomes in rheumatoid arthritis.
The Practitioner·2017
Diagnosing and managing mild cognitive impairment.
The Practitioner·2017
Be vigilant for dementia in Parkinson’s disease.
The Practitioner·2017
Meta-Analysis: Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors for Gastroprotection in Patients Receiving Antiplatelet Therapy.
Alimentary pharmacology & therapeutics·2026
Current practices, challenges, and future directions in subcutaneous oncology monoclonal antibody delivery: a qualitative study.
Expert opinion on drug delivery·2026
Ensuring patient rights, safety, and welfare in "compassionate use" of drugs.
Perspectives in clinical research·2026
Pediatric obesity pharmacotherapy: a practical guide for general pediatricians.
Current opinion in pediatrics·2026
Old Drugs, New Targets: Molecular Docking Insights into Repurposing Proton Pump Inhibitors for the TLR4/MD-2, NLRP3, and C5aR1 Axes in Autoimmune Liver Diseases.
Pharmaceuticals (Basel, Switzerland)·2026